Reporting owner · CIK 0001253886
Enright Patrick G
Visual SEC Form 4 history across 3 companies, 20 transactions and 5 filings.
DIRJazz Pharmaceuticals plc
Open-market mix
29%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.
- Window follows the rest of the summary (all-history or last 3 months).
- Only buys with a resolved price context are counted.
- Includes both positive and negative outcomes; gains and losses net out at the per-buy level.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Aug 25
$0
Jan 26
−$240.5K
Feb 26
$17.9M
Aug 26
$0
Transaction texture
Ownership and ticket size
Average P/S size$2.7M
Median P/S size$190.1K
Direct4
Indirect16
Aug 31, 2026withholding
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest sale
sale at RAPID MICRO BIOSYSTEMS, INC. on Feb 04, 2026 valued at $190,091.
Review SEC filingAssociated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| JAZZ | ENRIGHT PATRICK G | DIR | withholding | 1.69k | -$40.8M | F | 0.0% | 09/02 | 08/31 | |
| JAZZ | ENRIGHT PATRICK G | DIR | withholding | 14 | -$342k | F | 0.0% | 09/02 | 08/31 | |
| RPID | ENRIGHT PATRICK G | 10% | sale | 49.0k | -$19.0M | S | −33.9% | 02/06 | 02/04 | |
| MANE | ENRIGHT PATRICK G | DIR | grant | 45.1k | $0 | A | +180.3% | 02/06 | 02/03 | |
| MANE | ENRIGHT PATRICK G | DIR | C | 1.17M | — | C | +180.3% | 02/06 | 02/05 | |
| MANE | ENRIGHT PATRICK G | DIR | C | 1.17M | — | C | +180.3% | 02/06 | 02/05 | |
| MANE | ENRIGHT PATRICK G | DIR | C | 1.23M | — | C | +180.3% | 02/06 | 02/05 | |
| MANE | ENRIGHT PATRICK G | DIR | buy | 882k | $1.50B | P | +180.3% | 02/06 | 02/05 | |
| MANE | ENRIGHT PATRICK G | DIR | buy | 192k | $327M | P | +180.3% | 02/06 | 02/05 | |
| MANE | ENRIGHT PATRICK G | DIR | C | 1.17M | — | C | +180.3% | 02/06 | 02/05 |
Enright Patrick G Insider Activity FAQ
SEC Form 4 context
Who is Enright Patrick G?
Enright Patrick G is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001253886.
Which companies has Enright Patrick G reported transactions for?
Jazz Pharmaceuticals plc, RAPID MICRO BIOSYSTEMS, INC., Veradermics, Inc
When was Enright Patrick G's latest insider buy?
buy at Veradermics, Inc on Feb 05, 2026 valued at $15,000,001.
When was Enright Patrick G's latest insider sale?
sale at RAPID MICRO BIOSYSTEMS, INC. on Feb 04, 2026 valued at $190,091.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.